Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
OM Williams
Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
OT Ajai
Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
OC Idika
Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
AA Abolarinwa
Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
MA Bankole
Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
Main Article Content
Wilms’ Tumour: Experience in a Developing Tertiary Centre in Nigeria
RI Osuoji
OM Williams
OT Ajai
OC Idika
AA Abolarinwa
MA Bankole
Abstract
Background: Children with Wilms’ tumour present early in the developed countries with correspondingly good prognosis. The same however is not true in the developing countries where the patient present rather late. This study evaluates the impact of late presentation on the management of childhood Wilms’ tumour in our environment. Methods: This was a retrospective study of children aged 0-15 years managed for Wilms’ tumour from January 2004 to April 2010 in a Teaching Hospital in South Western Nigeria. Results: Thirty five patients that had nephroureterectomy for Wilms’ tumour with a histological confirmation were included in this study. One child had a Stage 1 disease, 9 had Stage II disease, 20 had Stage III disease, 4 had Stage IV disease and 1 child had a bilateral lesion (Stage V). Five (14.28%) patients have completed their chemotherapy and survived without clinical and radiological evidence of recurrence for a period equal to their age at diagnosis plus 9 months (Cullen’s law). Therefore they have been deemed cured. Ten patients were lost to follow-up. Others are on various phases of their chemotherapy, 2 patients had Adriamycin cardiomyopathy. There were 6 (17.14%) deaths. Conclusion: Childhood Wilms’ tumour presents late in our setting with its consequent management challenges. The need to educate the populace and the primary healthcare providers on the benefits of early diagnosis and treatment of this condition cannot be overemphasized.
East and Central African Journal of Surgery. 2011 Nov/ December;16 (3)
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.